Healthcare
Earth Science Tech Drives Shareholder Value Through Diversification and Buybacks
Earth Science Tech Inc. (ETST) has transformed into a diversified healthcare holding company, focusing on pharmaceutical compounding, telemedicine, and share repurchases to reduce dilution and enhance shareholder value.
Cardio Diagnostics to Showcase AI-Powered Heart Risk Solutions at National Benefits Conferences
Cardio Diagnostics Holdings will exhibit at four national benefits conferences in June, presenting AI-driven tools to help employers and plan administrators reduce cardiovascular disease costs and improve workforce health.
Cardio Diagnostics to Present AI Cardiovascular Tools at National Benefits Conferences
Cardio Diagnostics Holdings will showcase AI-powered cardiovascular risk solutions at four benefits conferences in June, aiming to help employers and plan administrators reduce healthcare costs and improve workforce health.
ORGANA International Highlights Summer Fatigue and the Role of Oxygen Support in Wellness Routines
ORGANA International emphasizes the impact of summer travel, heat, and activity on energy levels, promoting oxygen-support products as part of daily wellness routines.
NeuroOne Medical Technologies Restates Q2 Results Due to Revenue Recognition Error, Reaffirms FY2026 Guidance
NeuroOne Medical Technologies will restate its fiscal second-quarter financials after an error overstated revenue by $0.5 million, but the company reaffirms its full-year product revenue guidance of at least $10.5 million.
Helix BioPharma Grants Stock Options and Cancels Previous Grant Amid Pipeline Progress
Helix BioPharma Corp. announced the grant of 1,297,000 stock options to directors, officers, employees, and consultants, while canceling 2,200,000 options previously granted to a director, as the clinical-stage oncology company advances its pipeline including L-DOS47 and other candidates.
Growing Momentum for Single-Payer Health Care in Massachusetts Could Reshape National Policy
Massachusetts is at the forefront of a grassroots movement pushing for a single-payer health care system, driven by rising costs, with potential implications for federal health policy.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG Platform
HeartBeam Inc. is developing a cable-free, high-fidelity ECG platform to address pre-hospital delays in cardiac care, with potential for future heart attack detection.
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Solution for Knee Cartilage Repair, Targeting a 472,500-Procedure Gap
Regentis Biomaterials is developing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could fill a market gap as no approved off-the-shelf regenerative solution exists in the U.S., with a pivotal FDA trial now over 50% enrolled and a new manufacturing process boosting yield by 400%.
Brain Cell Division Errors May Unlock New Cancer Treatments, Study Finds
Researchers at the University of Virginia have discovered that errors in brain cell division during development could trigger cancer and developmental disorders, offering new pathways for treatment and prevention.
LataMed AI Surpasses 1,000 Platform Subscribers as It Develops Mobile Healthcare Apps for Apple and Google Stores
LataMed AI Corp. announced it has surpassed 1,000 early-stage platform subscribers while advancing development of mobile healthcare applications for the Apple App Store and Google Play, targeting underserved markets in Latin America.
Carmed Pharmaceuticals Gains CityBiz Feature as U.S. Expansion Accelerates
Carmed Pharmaceuticals, a Turkey-based company specializing in standardized carvacrol-based formulations, is highlighted in a CityBiz Q&A with founder Mustafa Can as it expands into the U.S. market through platforms like OneLavi and Amazon.
The Midwife in Vienna Brings European Midwifery Essentials to U.S. Market via OneLavi.com
The Austrian wellness brand expands its presence on OneLavi.com with three mother and baby care products rooted in traditional European midwifery, tapping into American demand for clean, minimalist alternatives.
AEVIS VICTORIA Shareholders Approve All Proposals at Annual General Meeting
AEVIS VICTORIA SA's Ordinary General Meeting approved all agenda items, including annual accounts and board renewals, reflecting stability and confidence in the company's strategy across healthcare, hospitality, and infrastructure.
Oncotelic Therapeutics Integrates 28 Million Scientific Abstracts into AI Platform, Signaling Shift in Drug Discovery
Oncotelic Therapeutics has integrated 28 million scientific abstracts into its PDAOAI platform, positioning itself as a key player in the rapidly growing AI drug-discovery market.
Scientists Make Progress on Blood Test for Early Lung Cancer Detection
Researchers are developing a blood test that could identify individuals at high risk for lung cancer, addressing the limitations of current screening focused solely on smoking history.
SureNano Science Targets Obesity Market with Novel GLP-1 Therapy GEP-44
SureNano Science Ltd. is advancing a differentiated GLP-1-based therapy, GEP-44, aiming to compete in the rapidly growing obesity and metabolic disease market dominated by blockbusters like Ozempic and Wegovy.
Optimi Health Prices $15 Million Public Offering for Nasdaq Uplisting, Aims to Scale Psychedelic Drug Production
Optimi Health Corp. has priced a $15 million public offering as it uplists to the Nasdaq Capital Market, planning to use proceeds to expand production and distribution of its GMP-grade psychedelic drug products for mental health therapies.
Power Orthodontics Opens New Practice Serving Halls and Knoxville, TN
Power Orthodontics has launched in Halls and Knoxville, Tennessee, offering braces and Invisalign to fill a gap for local orthodontic care, reducing travel for patients.
BioAdaptives Launches MyndSystem, a 24-Hour Cognitive Support Platform
BioAdaptives introduces MyndSystem, a dual-phase cognitive support platform combining daytime MyndMed and nighttime MyndRenew, originally developed for combat athletes.
Graphene Quantum Dots Show Promise in Targeting Parkinson's-Related Protein Clumping
A new study reveals that graphene quantum dots can interfere with the aggregation of misfolded proteins linked to Parkinson's disease, offering a potential new direction for therapeutic exploration.
Cardio Diagnostics CEO Outlines India Expansion and Medicare Progress in Podcast Interview
Cardio Diagnostics Holdings CEO Dr. Meesha Dogan discusses the company's growth strategy, including expansion into India and progress with Medicare reimbursement, highlighting the importance of precision medicine in cardiovascular disease prevention.
Datavault AI and Wellgistics Health Launch DelivMeds AI, a $4B Healthcare Platform
Datavault AI forms DelivMeds AI through a partnership with Wellgistics Health and strategic acquisitions, aiming to revolutionize healthcare delivery with AI, blockchain, and biometrics.
Sunshine Biopharma Raises $6 Million in Public Offering to Fund Operations and Drug Development
Sunshine Biopharma Inc. closed a $6 million public offering to support working capital and advance its proprietary drug programs for liver cancer and SARS-related coronaviruses.
Cardio Diagnostics CEO Outlines India Expansion and Medicare Progress on BioMedWire Podcast
Cardio Diagnostics Holdings CEO Dr. Meesha Dogan discussed the company's precision cardiovascular medicine strategy, including expansion into India via partnerships and completion of key Medicare reimbursement steps.
Datavault AI and Wellgistics Health Launch $4B DelivMeds AI Venture to Revolutionize Healthcare Delivery
Datavault AI and Wellgistics Health form DelivMeds AI, a healthcare platform valued at $4 billion, combining AI, blockchain, and biometric verification for nationwide data-driven healthcare delivery.
UNC Researchers Develop More Targeted Immunotherapy for Acute Myeloid Leukemia
Scientists at the University of North Carolina have engineered immune cells that selectively destroy acute myeloid leukemia while sparing healthy blood tissue, potentially expanding treatment options for patients.
Telomir Pharmaceuticals Reports Preclinical Data Showing Telomir-Zn Benefits in Wilson’s Disease Model
Telomir Pharmaceuticals announced peer-reviewed preclinical data demonstrating that Telomir-Zn improved survival and reduced oxidative stress and copper burden in a Wilson’s disease model, expanding the drug’s potential beyond its lead cancer program.
Annovis Bio Announces Public Offering to Fund Buntanetap Alzheimer's Trial
Annovis Bio has proposed a public offering of common stock and warrants to raise capital for its Phase 3 Alzheimer's study and general corporate purposes.
GeoVax Highlights MVA Platform's Potential Amid Bundibugyo Ebola Outbreak
GeoVax Labs comments on the WHO-declared PHEIC for Bundibugyo Ebola, emphasizing the need for flexible vaccine platforms like its MVA-based technology to address emerging viral threats.